Mogens Kruhoffer
Overview
Explore the profile of Mogens Kruhoffer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
2708
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kragsnaes M, Jensen J, Nilsson A, Malik M, Munk H, Pedersen J, et al.
RMD Open
. 2024 Jan;
10(1).
PMID: 38296309
Objectives: The gut microbiota can mediate both pro and anti-inflammatory responses. In patients with psoriatic arthritis (PsA), we investigated the impact of faecal microbiota transplantation (FMT), relative to sham transplantation,...
2.
Groiss S, Viertler C, Kap M, Bernhardt G, Mischinger H, Sieuwerts A, et al.
N Biotechnol
. 2023 Dec;
79:20-29.
PMID: 38072306
Cellular responses induced by surgical procedure or ischemia-reperfusion injury (IRI) may severely alter transcriptome profiles and complicate molecular diagnostics. To investigate this effect, we characterized such pre-analytical effects in 143...
3.
Mikkelsen E, Huppertz B, Singh R, Ravn K, Hatt L, Kruhoffer M, et al.
Int J Mol Sci
. 2023 Nov;
24(21).
PMID: 37958809
Clinically, unique markers in fetal membrane cells may contribute to the search for biomarkers for preterm prelabor rupture of the fetal membranes (pPROM) in maternal blood. pPROM is associated with...
4.
Masic D, Stengaard-Pedersen K, Logstrup B, Horslev-Petersen K, Hetland M, Junker P, et al.
Clin Exp Rheumatol
. 2023 Mar;
41(9):1801-1807.
PMID: 36995323
Objectives: To compare plasma levels of 92 cardiovascular- and inflammation-related proteins (CIRPs) and to analyse for associations with anti-cyclic citrullinated peptide (anti-CCP) status and disease activity in early and treatment-naive...
5.
Lukaszewski R, Jones H, Gersuk V, Russell P, Simpson A, Brealey D, et al.
Intensive Care Med
. 2022 Jul;
48(9):1133-1143.
PMID: 35831640
Purpose: Early accurate diagnosis of infection ± organ dysfunction (sepsis) remains a major challenge in clinical practice. Utilizing effective biomarkers to identify infection and impending organ dysfunction before the onset...
6.
Kragsnaes M, Kjeldsen J, Horn H, Munk H, Pedersen J, Just S, et al.
Ann Rheum Dis
. 2021 Jun;
82(7):e165.
PMID: 34158373
No abstract available.
7.
Mikkelsen L, Maag E, Klarskov Andersen M, Kruhoffer M, Larsen A, Melchior L, et al.
Melanoma Res
. 2020 Nov;
30(6):533-542.
PMID: 33156594
Herein, we wanted to explore the molecular landscape of mucosal melanoma from different sites and identify potential molecular targets for future therapy. Mucosal melanomas (N = 40) from different sites...
8.
Just J, Munk Ipsen P, Kruhoffer M, Lykkemark S, Skjold T, Schiotz P, et al.
Int Arch Allergy Immunol
. 2019 Apr;
179(2):102-107.
PMID: 30965334
Background: MicroRNAs (miRNAs) represent important post-transcriptional regulators with a dynamic expression profile during health and disease. Objectives: We explored the miRNA profile of human mast cells (MCs) during sen-sitization with...
9.
Zhang H, Korenkova V, Sjoback R, Svec D, Bjorkman J, Kruhoffer M, et al.
PLoS One
. 2014 Nov;
9(11):e111644.
PMID: 25369468
There is an increasing need for proper quality control tools in the pre-analytical phase of the molecular diagnostic workflow. The aim of the present study was to identify biomarkers for...
10.
Schou J, Rossi S, Jensen B, Nielsen D, Pfeiffer P, Hogdall E, et al.
PLoS One
. 2014 Jun;
9(6):e99886.
PMID: 24940606
Introduction: MicroRNAs (miRNAs) have important regulatory functions in cellular processes and have shown promising potential as prognostic markers for disease outcome in patients with cancer. The aim of the present...